Indications

The veterinary medicinal product is used in the target species in the following

situations:

1. Treatment of dehydration (in the absence of shock)

2. Parenteral rehydration

3. Correction of hypernatremia

4. Correction of hyperkalaemia

5. Transient supportive treatment of hypoglycaemia

Dosage and Administration

Usage:Intravenous use.

Dosage : Administer slowly via intravenous infusion. This product should not be administered at a rate in excess of 10 ml/kg bodyweight/hour, otherwise glycosuria and osmotic diuresis may result. Infusion rates should be calculated according to the presenting condition, bodyweight and degree of dehydration of the animal being treated. The total fluid volume to be administered should consider existing deficits, maintenance requirements and ongoing losses. IV fluids should be warmed up to body temperature prior to administration. Maintain aseptic precautions throughout administration. For single use only. Do not use unless the solution is clear, free from visible particles, and the container is undamaged.

Precautions & Warning:

Special precautions for use in animal This product does not contain electrolytes. Care should be taken to closely monitor electrolyte and phosphate balance in animals undergoing infusion of this product, and to adjust treatment accordingly. This product should be used with particular caution in animals with the following conditions:

1. Diabetes mellitus

2. Intracranial or intraspinal bleeding

3. Anuria

4. Addison’s disease 

5. Severe or long standing hypernatraemia should be corrected gradually. Special precautions to be taken by the person administering the veterinary medicinal product to animals None

Contraindications

Do not administer to hyperglycaemic animals. This product is unsuitable for the correction of hypotonic dehydration. Do not use in animals with pre-existing peripheral oedema caused by a reduction in intravascular oncotic pressure. This product is not suitable as a sole source of calorie requirements or as a substitute for oral or parenteral nutrition.

Adverse Reactions:

In very rare cases administration of products by intravenous infusion may increase the risk of thrombosis. The frequency of adverse reactions is defined using the following convention: - Very common (more than 1 in 10 animals treated displaying adverse reaction(s)). - Common (more than 1 but less than 10 animals in 100 animals treated). - Uncommon (more than 1 but less than 10 animals in 1,000 animals treated). - Rare (more than 1 but less than 10 animals in 10,000 animals treated). - Very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Overdose (symptoms, emergency procedures, antidotes), if necessary

Overperfusion can lead to overhydration, hypertension and extravascular fluid accumulation. Symptoms may include respiratory distress. In the case of overperfusion, reduce or cease fluid infusion and administer oxygen, diuretics and adjunctive treatment as necessary. Monitor respiration and heart rate, fluid output, electrolyte balance and blood glucose during administration. The administration of excess glucose can lead to hyperglycaemia, glycosuria and polyuria.

Drug interactions:

Incompatibilities with certain antibiotics (e.g. beta-lactam antibiotics, tetracyclines, sulfadiazine sodium) and heparin are recognised.

Storage instructions:

Keep the bottle protected from light.